UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 6,939 Shares of Plexus Corp. $PLXS

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in shares of Plexus Corp. (NASDAQ:PLXS) by 6.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,820 shares of the technology company’s stock after selling 6,939 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Plexus were worth $31,216,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Van ECK Associates Corp bought a new position in shares of Plexus in the second quarter worth about $6,645,000. Wellington Management Group LLP acquired a new stake in Plexus in the 2nd quarter valued at approximately $21,232,000. North Star Asset Management Inc. acquired a new stake in Plexus in the 2nd quarter valued at approximately $443,000. Empowered Funds LLC bought a new position in Plexus in the 2nd quarter worth approximately $284,000. Finally, Caitlin John LLC bought a new position in Plexus in the 2nd quarter worth approximately $74,000. 94.45% of the stock is owned by institutional investors and hedge funds.

Plexus Price Performance

Plexus stock opened at $242.07 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The business has a 50 day simple moving average of $259.30 and a 200 day simple moving average of $245.27. Plexus Corp. has a one year low of $132.03 and a one year high of $307.06. The company has a market capitalization of $6.48 billion, a PE ratio of 35.70 and a beta of 0.89.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period last year, the business earned $1.64 earnings per share. The business’s revenue was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, sell-side analysts forecast that Plexus Corp. will post 7.11 EPS for the current fiscal year.

Insider Buying and Selling at Plexus

In other news, CEO Todd P. Kelsey sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $294.98, for a total transaction of $442,470.00. Following the completion of the sale, the chief executive officer owned 68,888 shares of the company’s stock, valued at approximately $20,320,582.24. This trade represents a 2.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael V. Schrock sold 4,000 shares of Plexus stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the completion of the transaction, the director owned 40,329 shares of the company’s stock, valued at $11,090,475. This trade represents a 9.02% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,500 shares of company stock worth $2,039,375 over the last ninety days. Corporate insiders own 1.78% of the company’s stock.

Analyst Ratings Changes

PLXS has been the subject of several research reports. Weiss Ratings cut Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 11th. Needham & Company LLC reiterated a “buy” rating and set a $310.00 target price on shares of Plexus in a research note on Friday, August 14th. Stifel Nicolaus raised their price target on shares of Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Finally, Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a research note on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. Based on data from MarketBeat, Plexus presently has an average rating of “Buy” and a consensus target price of $273.00.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.